New quarterly report expected Apr 28, 2026. Report will refresh after results.
K
The Coca-Cola Company
KO · Consumer Defensive
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 10, 2026
The World's Best Tollbooth Is Charging Too Much to Enter
Most investors see Coca-Cola as a safe bond proxy and price it accordingly — the real question nobody is asking loudly enough is whether the FCF halving since 2021 is temporary investment-cycle noise or the first visible symptom of a business that requires structurally more capital to sustain itself than the asset-light mythology has always promised.
Flowly Score
Apr 16 Close
-4%$75.18
Fair Value
$72.00
51
Averageat $75.18
Business Strength8/10
One of the most elegant royalty businesses ever constructed — the concentrate model keeps capital burden off the balance sheet while the brand does 140 years of selling for free. The only genuine vulnerability is whether the category itself slowly shrinks rather than any competitor winning.
Financial Resilience6/10
The Piotroski 7 and Altman Z above distress territory signal a structurally sound balance sheet, but FCF more than halving from peak while capex triples as a share of operating cash is a real deterioration in cash quality that deserves more than a footnote. Debt load is substantial and the earnings-to-cash conversion inversion two years running is the kind of thing that looks benign until it isn't.
Growth & Trajectory5/10
Volume essentially flat, revenue gains almost entirely price-driven, and the new CEO openly admitting innovation is not where it needs to be — this is a business managing decline velocity rather than pursuing growth. Zero Sugar's trajectory and fairlife's early scale offer genuine optionality, but they are not yet large enough to move the needle on a company this size.
Valuation3/10at $77.80
The neutral DCF sits well below the current price, the FCF yield barely registers, and the EV/FCF multiple is pricing in a cash generation recovery that has not materialized for years. The moat is real but the multiple demands perfection from a business delivering flat volumes and compressing free cash flow.
Risk6/10
Geographic diversification across every continent is genuine protection against any single regional shock, and 32 billion-dollar brands means no single product failure is catastrophic. But GLP-1 demand disruption, spreading sugar taxes in Europe and Latin America, and a live IRS transfer pricing dispute that challenges the fundamental structure of the licensing model are three non-trivial risks arriving simultaneously.
The investment case rests on a genuine tension: this is unquestionably a world-class business — arguably the most recognizable commercial brand in history attached to a capital-light royalty machine — but quality and price are different questions, and the price being charged today embeds assumptions about cash generation recovery that the actual reported numbers do not yet support. You are being asked to pay a premium for a business delivering flat volumes, price-only revenue growth, and an FCF yield that competes poorly against risk-free alternatives. The trajectory story is more nuanced than the bears allow. Zero Sugar's sustained momentum proves the brand can navigate the health transition — consumers want the Coca-Cola ritual, not specifically the sugar, which is a structurally important finding. Fairlife is a genuine category bet that could prove transformative if protein-nutrition premium dairy scales the way early volumes suggest. The incoming CEO's blunt acknowledgment that innovation is underperforming is actually a bullish signal — it means the organization is diagnosing the problem rather than papering over it with 'comparable' metrics. The single biggest specific risk is the IRS transfer pricing dispute. This is not a routine audit — the Tax Court has already found against the company on how it prices the brand license between the US parent and its foreign subsidiaries, which is the exact mechanism that makes the asset-light model work. An adverse final resolution could permanently reset the tax burden embedded in the concentrate licensing model, altering the economics of the entire business structure in ways the current valuation does not remotely contemplate.